Efficacy and Safety of Nipocalimab in Adults With Generalised Myasthenia Gravis: An Asian Subgroup Analysis of the Vivacity-MG3 Study.

Nagane Y, Yang H, Park JS, Yeh JH, Turkoz I, Makanji Y

Open source

DOI
10.3988/jcn.2025.0290
Published
2026 Jul
Container
Journal of clinical neurology (Seoul, Korea)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3988/jcn.2025.0290,
  title = {Efficacy and Safety of Nipocalimab in Adults With Generalised Myasthenia Gravis: An Asian Subgroup Analysis of the Vivacity-MG3 Study.},
  author = {Nagane Y and Yang H and Park JS and Yeh JH and Turkoz I and Makanji Y},
  year = {2026},
  journal = {Journal of clinical neurology (Seoul, Korea)},
  doi = {10.3988/jcn.2025.0290},
  url = {https://doi.org/10.3988/jcn.2025.0290}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Nipocalimab in Adults With Generalised Myasthenia Gravis: An Asian Subgroup Analysis of the Vivacity-MG3 Study.
AU  - Nagane Y
AU  - Yang H
AU  - Park JS
AU  - Yeh JH
AU  - Turkoz I
AU  - Makanji Y
PY  - 2026
JO  - Journal of clinical neurology (Seoul, Korea)
DO  - 10.3988/jcn.2025.0290
UR  - https://doi.org/10.3988/jcn.2025.0290
ER  - 

APA

Y, N., H, Y., JS, P., JH, Y., I, T., & Y, M. (2026). Efficacy and Safety of Nipocalimab in Adults With Generalised Myasthenia Gravis: An Asian Subgroup Analysis of the Vivacity-MG3 Study.. Journal of clinical neurology (Seoul, Korea). https://doi.org/10.3988/jcn.2025.0290

Source records